Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-IP19-001, Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaskan Natives; IP19-002, Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Practices in Large Health Systems Through Quality Improvement Interventions and IP19-003, Understanding and Improving Immunization Services Among Adult Hospital Inpatient and Observation/Clinical Decision Unit Settings; Amended Notice of Meeting, 5445-5446 [2019-02909]

Download as PDF 5445 Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices 1999–2002, 2007–08, 2009–10, 2011–12 complete set Total costs Materials and Equipment—contractor: Plates, reagents, assays, aliquoting and packaging samples; use of equipment ...................................................................................................... Labor—contractor: Processing, handling, and shipping; NCHS: Data quality control ................ Proposal review and Administrative expenses—contractor: Inventory management and reporting; NCHS: Management of proposal process non-NCHS: Technical panel fees ............ Space—contractor: Freezer use and maintenance ..................................................................... Cost per sample .......................................................................................................................... Cost per new proposal: 1999–2002 ............................................................................................................................ 2007–2008 ............................................................................................................................ 2009–2010 ............................................................................................................................ 2011–2012 ............................................................................................................................ III ........................................................................................................................................... Cost per additional proposal: ** 1999–2002 ............................................................................................................................ 2007–2008 ............................................................................................................................ 2009–2010 ............................................................................................................................ 2011–2012 ............................................................................................................................ III ........................................................................................................................................... 1999–2002, 2007–08, 2009–10, 2011–12 partial set NHANES III complete set $1.51 4.98 $4.53 24.90 $0.75 2.49 3.02 5.59 15.10 6.04 5.59 41.06 1.51 2.79 7.55 118,369 69,641 73,884 62,605 ........................ * ........................ ........................ ........................ ........................ ........................ ........................ ........................ 54,050 ........................ 5,918 3,633 3,694 3,131 ........................ *** ........................ ........................ ........................ ........................ ........................ ........................ ........................ 2,702 ........................ * Cost calculated upon request. ** Additional research using DNA samples already obtained from previous solicitations. *** This charge will be 5 percent of the original cost. Note: Applicable CDC overhead and NCHS management and oversight charges will be added to these rates for proposals coming from Federal agencies. Dated: February 14, 2019. Sandra Cashman, Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2019–02908 Filed 2–20–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amozie on DSK3GDR082PROD with NOTICES1 Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and VerDate Sep<11>2014 17:08 Feb 20, 2019 Jkt 247001 Control Special Emphasis Panel (SEP)— RFA–CE–19–005, Research Grants for Preventing Violence and Violence Related Injury. Date: May 14–15, 2019. Time: 8:30 a.m.–5:30 p.m., EDT. Place: Atlanta Marriott Buckhead and Conference Center, 3405 Lenox Road NE, Atlanta, GA 30326. Agenda: To review and evaluate grant applications. For Further Information Contact: Mikel Walters, Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404) 639– 0913, MWalters@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–02949 Filed 2–20–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—IP19–001, Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaskan Natives; IP19–002, Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Practices in Large Health Systems Through Quality Improvement Interventions and IP19– 003, Understanding and Improving Immunization Services Among Adult Hospital Inpatient and Observation/ Clinical Decision Unit Settings; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—IP19– 001, Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaskan Natives; IP19–002, Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Practices in Large Health Systems through Quality Improvement Interventions and IP19– 003, Understanding and Improving Immunization Services Among Adult Hospital Inpatient and Observation/ Clinical Decision Unit Settings; March 19–20, 2019; 10:00 a.m.–5:00 p.m., E:\FR\FM\21FEN1.SGM 21FEN1 5446 Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Agency Information Collection Activities: Proposed Collection; Comment Request; Correction [FR Doc. 2019–02909 Filed 2–20–19; 8:45 am] [FR Doc. 2019–02910 Filed 2–20–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10280] Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Correction of notice. BILLING CODE 4163–18–P AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES SUMMARY: Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PS19–003, Using Real-Time Prescription and Insurance Claims Data To Support the HIV Care Continuum; Amended Notice of Meeting amozie on DSK3GDR082PROD with NOTICES1 The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. (EDT) which was published in the Federal Register on November 26, 2018, Volume 83, Number 227, page 60427. The meeting is being amended to change the date. The date should read as follows: March 20, 2019; 10:00 a.m.– 5:00 p.m. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30333, (404) 718–8833, gca5@ cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PS19– 003, Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum; March 6–7, 2019, 10:00 a.m.–5:00 p.m., (EST), Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329 which was published in the Federal Register on December 26, 2018, Volume 83, Number 246, pages 66267. The meeting is being amended to change the date. The date should read as follows: March 6, 2019; 10:00 a.m.– 5:00 p.m. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30333, (404) 718–8833, gca5@ cdc.gov. VerDate Sep<11>2014 17:08 Feb 20, 2019 Jkt 247001 This document corrects the information provided for [Document Identifier: CMS–10180] titled ‘‘Home Health Change of Care Notice.’’ FOR FURTHER INFORMATION CONTACT: William N. Parham, III, (410) 786–4669. SUPPLEMENTARY INFORMATION: I. Background In the February 14, 2019, issue of the Federal Register (84 FR 7073), we published a Paperwork Reduction Act notice requesting a 30-day public comment period for the information collection request identified under CMS–10180, OMB control number 0938–1196, and titled ‘‘Home Health Change of Care Notice.’’ II. Explanation of Error Frm 00043 Fmt 4703 Sfmt 4703 III. Correction of Error In FR Doc. 2019–02235 of February 14, 2019 (84 FR 4073), page 7073, the language in the third column, at the top of the notice that begins with ‘‘[Document Identifier’’ and ends with ‘‘and CMS–10440],’’ is corrected to read as follows: [Document Identifier: CMS–10680, CMS–10280 and CMS–10440] In FR Doc. 2019–02235 of February 14, 2019 (84 FR 4073), page 7074, the language in the third column, in the second paragraph in that column that begins with ‘‘Form Number’’ and ends with ‘‘Frequency: Reporting—Annually; Affected Public: State, Local or Tribal governments,’’ is corrected to read as follows: Form Number: CMS–10280 (OMB control number: 0938–1196); Frequency: Reporting—Annually; Affected Public: State, Local or Tribal governments. Dated: February 14, 2019. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2019–02793 Filed 2–20–19; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–179] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: In the February 14, 2019, notice, the information provided in the third column at the top of notice, on page 4073, was published with incorrect information in the ‘‘Document Identifier’’ section. This notice corrects the language found in the ‘‘Document Identifier’’ section under the third column at the top of notice, on page 4073 of the February 14th notice. Also in the February 14, 2019, notice, the information provided in the third column under paragraph 2, on page 7074, was published with incorrect information in the ‘‘Form Number.’’ This notice corrects the language found in the ‘‘Form Number’’ section under PO 00000 the 2nd paragraph on page 7074 of the February 14th notice. All of the other information contained in the February 14, 2019, notice is now correct. The related public comment period remains in effect and ends March 18, 2019. The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested SUMMARY: E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Pages 5445-5446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02909]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--IP19-001, Surveillance for Respiratory Syncytial 
Virus (RSV) and Other Viral Respiratory Infections Among Native 
Americans/Alaskan Natives; IP19-002, Increasing Influenza and Tdap 
Vaccination of Pregnant Women in Obstetric/Gynecologic Practices in 
Large Health Systems Through Quality Improvement Interventions and 
IP19-003, Understanding and Improving Immunization Services Among Adult 
Hospital Inpatient and Observation/Clinical Decision Unit Settings; 
Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--IP19-001, Surveillance for Respiratory Syncytial Virus (RSV) and 
Other Viral Respiratory Infections Among Native Americans/Alaskan 
Natives; IP19-002, Increasing Influenza and Tdap Vaccination of 
Pregnant Women in Obstetric/Gynecologic Practices in Large Health 
Systems through Quality Improvement Interventions and IP19-003, 
Understanding and Improving Immunization Services Among Adult Hospital 
Inpatient and Observation/Clinical Decision Unit Settings; March 19-20, 
2019; 10:00 a.m.-5:00 p.m.,

[[Page 5446]]

(EDT) which was published in the Federal Register on November 26, 2018, 
Volume 83, Number 227, page 60427.
    The meeting is being amended to change the date. The date should 
read as follows: March 20, 2019; 10:00 a.m.-5:00 p.m. The meeting is 
closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, 
Atlanta, Georgia 30333, (404) 718-8833, gca5@cdc.gov. The Chief 
Operating Officer, Centers for Disease Control and Prevention, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-02909 Filed 2-20-19; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.